LDNscience

LDNscience® helps increase patient access to Low-Dose Naltrexone, a life-changing treatment for MS, F MedInsight® Research Institute is a U.S./U.K.

LDNscience® helps increase patient access to Low-Dose Naltrexone, a life-changing treatment for MS, Fibromyalgia, Crohn’s and other autoimmune and chronic conditions. LDNscience® is a public information project of the MedInsight® Research Institute. based non-profit organization established in 2006, that serves as a platform for researching and indexing available off-label (repurposed) treatments for cancer and chronic diseases. MedInsight employs a graph-oriented database to drive innovation in the field of drug repurposing. Under the leadership of Moshe Rogosnitzky, a scientist and MedInsight's co-founder, LDNscience brings together research and information on Low Dose Naltrexone (LDN) and its application in the treatment of chronic and serious diseases. We collaborate with LDN researchers to bring current information about clinical trials and research to patients, the general public and professional community.

Address

1732 1st Avenue #23222
New York, NY
10128

Website

https://www.ldnscience.org/donate

Alerts

Be the first to know and let us send you an email when LDNscience posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.